Behavioural Alterations in Rats Following Neonatal Hypoxia and Effects of Clozapine: Implications for Schizophrenia

 

 Buy Article Permissions and Reprints

Abstract

Introduction: As a consequence of obstetric complications hypoxia has been discussed as a possible factor in the pathophysiology of schizophrenia. The present study investigated the effects of weak chronic neonatal hypoxia in rats on different behavioural animal models of schizophrenia.

Methods: (1) After neonatal hypoxia, half of the pups were fostered by normally treated nurse animals to control for possible maternal effects. (2) The animals were tested on postnatal days (PD) 36, 86, 120 and 150 by applying three different behavioural tests: prepulse inhibition (PPI), social interaction and recognition, and motor activity in an open field. (3) Before the PD 150 test, half of the animals had been chronically treated with the antipsychotic drug clozapine (45 mg/kg/day).

Results: Rats exposed to hypoxia as neonates exhibited a deficit in locomotor activity on PD 86, 120, and 150, as well as a PPI deficit on PD 120 and 150 but not before. Chronic treatment with clozapine reverses the hypoxia induced PPI deficit, but not the decreased locomotor activity. In a second experiment, clozapine was chronically administered before PD 120 and blocked the development of the PPI deficit in the animals exposed to hypoxia.

Discussion: The time course of the hypoxia-induced PPI deficit and reversibility by clozapine supports the validity of our animal model and the hypothesis that hypoxia as an obstetric complication is an important factor in the pathophysiology of schizophrenia.

References

• 1 Auclair AL, Kleven MS, Besnard J, Deporteere R, Newman-Tancredi A. Actions of novel antipsychotic agents on apomorphine-induced PPI disruption: influence on combined serotonin 5-HT1A receptor activation and dopamine D2 receptor blockade.  Neuropsychopharmacology. 2006;  31 1900-1909
  CrossrefPubMedGoogle Scholar
• 2 Bakshi VP, Swerdlow NR, Geyer MA. Clozapine antagonizes phencyclidine-induced defitits in sensorimotor gating of the startle response.  J Pharmacol Exp Ther. 1994;  271 787-794
  PubMedGoogle Scholar
• 3 Braff DL, Geyer MA, Swerdlow NR. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies.  Psychopharmacology. 2001;  156 234-258
  CrossrefPubMedGoogle Scholar
• 4 Braff DL, Grillon C, Geyer MA. Gating and habituation of the startle reflex in schizophrenic patients.  Arch Gen Psychiatry. 1992;  49 206-215
  CrossrefPubMedGoogle Scholar
• 5 Braff DL, Swerdlow NR, Geyer MA. Symptom correlates of prepulse inhibition deficits in male schizophrenic patients.  Am J Psychiatry. 1999;  156 596-602
  PubMedGoogle Scholar
• 6 Bymaster FP, Calligaro DO, Falcone JF, Marsh RD, Moore NA, Tye NC, Seeman P, Wong DT. Radioreceptor binding profile of the atypical antipsychotic olanzapine.  Neuropsychopharmacology. 1996;  14 87-96
  PubMedGoogle Scholar
• 7 Cannon TD, Mednick SA. Fetal neural development and adult schizophrenia: An elaboration of the paradigm. In: Mednick SA, Cannon TD, Barr CE, editors. Fetal neural development and adult schizophrenia. Cambridge: Cambridge University Press 1991: 227-237
  Google Scholar
• 8 Cannon TD, Rosso IM, Bearden CE, Sanchez LE, Hadley T. A prospective cohort study of neurodevelopmental processes in the genesis and epigenesis of schizophrenia.  Dev Psychopathol. 1999;  11 467-485
  CrossrefPubMedGoogle Scholar
• 9 Cannon TD, Erp TG Van, Rosso IM, Huttunen M, Lonnqvist J, Pirkola T, Salonen O, Valanne L, Poutanen VP, Standertskjold-Nordenstam CG. Fetal hypoxia and structural brain abnormalities in schizophrenic patients, their siblings, and controls.  Arch Gen Psychiatry. 2002;  59 35-41
  CrossrefPubMedGoogle Scholar
• 10 Carlsson A. The neurochemical circuitry of schizophrenia.  Pharmacopsychiatry. 2006;  39 10-14
  Article in Thieme ConnectPubMedGoogle Scholar
• 11 Dalman C, Thomas HV, Davis AS, Gentz J, Lewis G, Allebeck P. Signs of asphyxia at birth and risk of schizophrenia. Population-based case-control study.  Br J Psychiatry. 2001;  179 403-408
  CrossrefPubMedGoogle Scholar
• 12 Dobbing J, Sands J, Gatrix CA. Cell size and cell number: a reconsideration of organ growth and catch-up potential.  Proc Nutr Soc. 1979;  38 99A
  CrossrefPubMedGoogle Scholar
• 13 El-Khodor BF, Boksa P. Transient birth hypoxia increases behavioral responses to repeated stress in the adult rat.  Behav Brain Res. 2000;  107 171-175
  CrossrefPubMedGoogle Scholar
• 14 El-Khodor BF, Boksa P. Differential vulnerability of male versus female rats to long-term effects of birth insult on brain catecholamine levels.  Exp Neurol. 2003;  182 208-219
  CrossrefPubMedGoogle Scholar
• 15 Goodman R. Are complications of pregnancy and birth causes of schizophrenia?.  Dev Med Child Neurol. 1988;  30 391-395
  PubMedGoogle Scholar
• 16 Häfner H, an der Heiden W, Behrens S, Gattaz WF, Hambrecht M, Löffler W, Maurer K, Munk-Jorgensen P, Nowotny B, Riecher-Rössler A, Stein A. Causes and consequences of the gender difference in age at onset of schizophrenia.  Schiz Bull. 1998;  24 99-113
  CrossrefPubMedGoogle Scholar
• 17 Hermans RH, Longo LD. Altered catecholaminergic behavioral and hormonal responses in rats following early postnatal hypoxia.  Physiol Behav. 1994;  55 469-475
  CrossrefPubMedGoogle Scholar
• 18 Ikonomidou C, Mosinger JL, Salles KS, Labruyere J, Olney JW. Sensitivity of the developing rat brain to hypobaric/ischemic damage parallels sensitivity to N-methyl-aspartate neurotoxicity.  J Neurosci. 1989;  9 2809-2818
  PubMedGoogle Scholar
• 19 Karow A, Schnedler D, Naber D. What would the patient choose? Subjective comparison of atypical and typical neuroleptics.  Pharmacopsychiatry. 2006;  39 47-51
  Article in Thieme ConnectPubMedGoogle Scholar
• 20 Krajnc D, Wemlinger TA, Neff NH, Hadjiconstantinou M. Neonatal hypoxia: early neurotransmitter responses and the consequences of treatment with GM1 ganglioside.  J Pharmacol Exp Ther. 1994;  271 1299-1305
  PubMedGoogle Scholar
• 21 Kumari V, Sharma T. Effects of typical and atypical antipsychotics on prepulse inhibition in schizophrenia: a critical evaluation of current evidence and directions for future research.  Psychopharmacology. 2002;  162 97-101
  CrossrefPubMedGoogle Scholar
• 22 Kusljic S, Brosda J, Buuse M van der. Effects of haloperidol and clozapine on sensorimotor gating deficits induced by 5-hydroxytryptamine depletion in the brain.  Br J Pharmacol. 2006;  147 800-807
  CrossrefPubMedGoogle Scholar
• 23 Le Pen G, Moreau JL. Disruption of prepulse inhibition of startle reflex in a neurodevelopmental model of schizophrenia: reversal by clozapine, olanzapine and risperidone but not by haloperidol.  Neuropsychopharmacology. 2002;  27 1-11
  CrossrefPubMedGoogle Scholar
• 24 Leung A, Chue P. Sex differences in schizophrenia, a review of the literature.  Acta Psychiatr Scand Suppl. 2000;  401 3-38
  PubMedGoogle Scholar
• 25 Lewis SW, Barnes TR, Davies L, Murray RM, Dunn G, Hayhurst KP, Markwick A, Lloyd H, Jones PB. Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia.  Schizophr Bull. 2006;  32 715-723
  Google Scholar
• 26 Linn GS, Negi SS, Gerum SV, Javitt DC. Reversal of phencyclidine-induced prepulse inhibition deficits by clozapine in monkeys.  Psychopharmacology. 2003;  169 234-239
  CrossrefPubMedGoogle Scholar
• 27 Lipska BK, Al-Amin HA, Weinberger DR. Excitotoxic lesions of the rat medial prefrontal cortex. Effects on abnormal behaviors associated with neonatal hippocampal damage.  Neuropsychopharmacology. 1998;  19 451-464
  CrossrefPubMedGoogle Scholar
• 28 Lipska BK, Aultman JM, Verma A, Weinberger DR, Moghaddam B. Neonatal damage of the ventral hippocampus impairs working memory in the rat.  Neuropsychopharmacology. 2002;  27 47-54
  CrossrefPubMedGoogle Scholar
• 29 MacNeil TF. Obstetric factors and perinatal injuries. In Tsuang MT, Simpson JC, editors. Handbook of schizophrenia, vol 3: Nosology, epidemiology and genetics. New York: Elsevier 1988: 319-344
  Google Scholar
• 30 MacNeil TF, Cantor-Graae E, Weinberger DR. Relationship of obstetric complications and differences in size of brain structures in monozygotic twin pairs discordant for schizophrenia.  Am J Psychiatry. 2000;  157 203-212
  CrossrefPubMedGoogle Scholar
• 31 Meincke U, Morth D, Voss T, Thelen B, Geyer MA, Gouzoulis-Mayfrank E. Prepulse inhibition of the acoustically evoked startle reflex in patients with an acute schizophrenic psychosis – a longitudinal study.  Eur Arch Psychiatry Clin Neurosci. 2004;  254 415-421
  CrossrefPubMedGoogle Scholar
• 32 Oranje B, Oel CJ van, Gispen-De Wied MN, Kahns RS. Effects of typical and atypical antipsychotics on the prepulse inhibition of the startle reflex in patients with schizophrenia.  J Clin Psychopharmacol. 2002;  22 359-365
  CrossrefPubMedGoogle Scholar
• 33 Pearigen P, Gwinn R, Simon RP. The effects in vivo of hypoxia on brain injury.  Brain Res. 1996;  725 184-191
  PubMedGoogle Scholar
• 34 Perry W, Braff DL. Information-processing deficits and thought disorder in schizophrenia.  Am J Psychiatry. 1994;  151 363-367
  PubMedGoogle Scholar
• 35 Perry W, Geyer MA, Braff DL. Sensorimotor gating and thought disturbance measured in close temporal proximity in schizophrenic patients.  Arch Gen Psychiatry. 1999;  56 277-281
  CrossrefPubMedGoogle Scholar
• 36 Putzhammern A, Klein HE. Quantitative analysis of motor disturbances in schizophrenic patients.  Dialogues Clin Neurosci. 2006;  8 123-130
  PubMedGoogle Scholar
• 37 Romero A, Villamayor F, Grau MT, Sacristan A, Ortiz JA. Relationship between fetal weight and litter size in rats: application to reproductive toxicology studies.  Reprod Toxicol. 1992;  6 453-456
  CrossrefPubMedGoogle Scholar
• 38 Rung JP, Carlsson A, Ryden Markinhuhta K, Carlsson ML. MK-801 induced social withdrawal in rats; a model for negative symptoms of schizophrenia.  Prog Neuro-Psychopharmacol & Biol Psychiat. 2005;  29 827-832
  PubMedGoogle Scholar
• 39 Rygula R, Abumaria N, Flügge G, Fuchs E, Ruther E, Havemann-Reinecke U. Anhedonia and motivational deficits in rats: impact of chronic social stress.  Behav Brain Res. 2005;  162 127-134
  CrossrefPubMedGoogle Scholar
• 40 Sams-Dodd F, Lipska BK, Weinberger DR. Neonatal lesions of the rat ventral hippocampus result in hyperlocomotion and deficits in social behaviour in adulthood.  Psychopharmacology. 1997;  132 303-310
  CrossrefPubMedGoogle Scholar
• 41 Sandager-Nielsen K, Andersen MB, Sager TN, Werge T, Scheel-Krüger J. Effects of postnatal anoxia on striatal dopamine metabolism and prepulse inhibition in rats.  Pharmacol Biochem Behav. 2004;  77 767-774
  CrossrefPubMedGoogle Scholar
• 42 Schmitt A, Fendt M, Zink M, Ebert U, Starke M, Berthold M, Herb A, Petroianu G, Falkai P, Henn FA. Altered NMDA receptor expression and behavior following postnatal hypoxia: potential relevance to schizophrenia.  J Neural Transm. 2007;  114 239-248
  CrossrefPubMedGoogle Scholar
• 43 Schmitt A, Zink M, Müller B, May B, Herb A, Jatzko A, Braus DF, Henn FA. Effects of long-term antipsychotic treatment on NMDA receptor binding and gene expression of subunits.  Neurochem Res. 2003;  28 235-241
  CrossrefPubMedGoogle Scholar
• 44 Schmitt A, Zink M, Petroianu G, May B, Braus DF, Henn FA. Decreased gene expression of glial and neuronal glutamate transporters after chronic antipsychotic treatment in rat brain.  Neurosci Lett. 2003;  347 81-84
  CrossrefPubMedGoogle Scholar
• 45 Schmitt U, Dahmen N, Fischer V, Weigmann H, Rao M-L, Reuss S, Hiemke C. Chronic oral haloperidol and clozapine in rats: A behavioral evaluation.  Neuropsychobiology. 1999;  39 86-91
  CrossrefPubMedGoogle Scholar
• 46 Schneider M, Koch M. Behavioral and morphological alterations following neonatal excitotoxic lesions of the medial prefrontal cortex in rats.  Exp Neurol. 2005;  195 185-198
  CrossrefPubMedGoogle Scholar
• 47 Schneider M, Koch M. Deficient social and play behavior in juvenile and adult rats after neonatal cortical lesion: effects of chronic pubertal cannabinoid treatment.  Neuropsychopharmacology. 2005;  30 944-957
  CrossrefPubMedGoogle Scholar
• 48 Susser ES, Lin SP. Schizophrenia after prenatal exposure to the Dutch Hunger Winter of 1944-1945.  Arch Gen Psychiatry. 1992;  49 983-988
  CrossrefPubMedGoogle Scholar
• 49 Swerdlow NR, Geyer MA. Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia.  Pharmacol Biochem Behav. 1993;  44 741-744
  CrossrefPubMedGoogle Scholar
• 50 Swerdlow NR, Geyer MA. Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia.  Schizophr Bull. 1998;  24 285-301
  PubMedGoogle Scholar
• 51 Swerdlow NR, Geyer MA, Braff DL. Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges.  Psychopharmacology. 2001;  156 194-215
  CrossrefPubMedGoogle Scholar
• 52 Swerdlow NR, Light GA, Cadenhead KS, Sprock J, Hsieh MH, Braff DL. Startle gating deficits in a large cohort of patients with schizophrenia: relationship to medications, symptoms, neurocognition, and level of function.  Arch Gen Psychiatry. 2006;  63 1325-1335
  CrossrefPubMedGoogle Scholar
• 53 Thor DH, Holloway WR. Social memory of the male laboratory rat.  J Comp Physiol Psychol. 1982;  96 1000-1006
  CrossrefPubMedGoogle Scholar
• 54 Vaillancourt C, Boksa P. Birth insult alters dopamine-mediated behavior in a precocial species, the guinea pig. Implications for schizophrenia.  Neuropsychopharmacology. 2000;  23 654-666
  CrossrefPubMedGoogle Scholar
• 55 Buuse M van den, Garner B, Koch M. Neurodevelopmental animal models of schizophrenia: effects on prepulse inhibition.  Curr Mol Med. 2003;  3 459-471
  CrossrefPubMedGoogle Scholar
• 56 Erp TG Van, Saleh PA, Rosso IM, Huttunen M, Lonnqvist J, Pirkola T, Salonen O, Valanne L, Poutanen VP, Standertskjold-Nordenstam CG, Cannon TD. Contributions of genetic risk and fetal hypoxia to hippocampal volume in patients with schizophrenia or schizoaffective disorder, their unaffected siblings, and healthy unrelated volunteers.  Am J Psychiatry. 2002;  159 1514-1520
  CrossrefPubMedGoogle Scholar
• 57 Verdoux H, Geddes JR, Takei N, Lawrie SM, Bovet P, Eagles JM, Heun R, MacCreadie RG, MacNeil TF, O'Callaghan E, Stober G, Willinger MU, Wright P, Murray RM. Obstetric complications and age at onset in schizophrenia: an international collaborative meta-analysis of individual patient data.  Am J Psychiatry. 1997;  154 1220-1227
  PubMedGoogle Scholar
• 58 Weike AI, Bauer U, Hamm AO. Effective neuroleptic mediaction removes prepulse inhibition deficits in schizophrenic patients.  Biol Psychiatry. 2000;  47 61-70
  CrossrefPubMedGoogle Scholar
• 59 Weinberger DR. Implications of normal brain development for the pathogenesis of schizophrenia.  Arch Gen Psychiatry. 1987;  44 660-669
  PubMedGoogle Scholar
• 60 Weinberger DR. On the plausibility of „the neurodevelopmental hypothesis” of schizophrenia.  Neuropsychopharmacology. 1996;  14 1-11
  CrossrefPubMedGoogle Scholar
• 61 Weinberger DR, Lipska BK. Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground.  Schizophr Res. 1995;  16 37-110
  PubMedGoogle Scholar
• 62 Zink M, Schmitt A, May B, Müller B, Braus DF, Henn FA. Differential effects of long-term treatment with clozapine or haloperidol on GABA transporter expression.  Pharmacopsychiatry. 2004;  37 171-174
  Article in Thieme ConnectPubMedGoogle Scholar
• 63 Zink M, Schmitt A, May B, Müller B, Demirakca T, Braus DF, Henn FA. Differential effects of long-term treatment with clozapine or haloperidol on GABAA receptor binding and GAD67 expression.  Schizophr Res. 2004;  66 151-157
  CrossrefPubMedGoogle Scholar

Correspondence

Dr. M. Fendt

Novartis Institutes of BioMedical Research

DA Neuroscience

WSJ-386.3.44

Forum 1

Novartis Campus

4056 Basel

Switzerland

Phone: +41/61/324 10 42

Fax: +41/6/324 45 02

Email: markus.fendt@novartis.com